Source / episode info
- **Episode:**381
- **Title:**Divine Intervention Episode 381 – Some HY Pharmacology Vignettes for Step 2CK/3
- **Published:**2022-03-28
- Source:Episode page
One-liner
This episode provides high-yield vignettes covering acetaminophen overdose management (NAC rescue), the nephrotoxic effects of ACE inhibitors (efferent arteriole dilation and RAS risk), indications for ACEi/ARBs in specific comorbidities (diabetes, CKD, scleroderma), and endocrine/neurological pharmacology involving dopamine agonists (prolactinoma treatment and Parkinsonism).
High-yield summary
- Acetaminophen Toxicity: Overdose leads to hepatotoxicity via the metabolite NAPQI. Treatment requires N-acetylcysteine (NAC), which replenishes glutathione stores. Crucial: Acetaminophen is NOT an NSAID.
- ACE Inhibitors/ARBs: These drugs are renally protective in patients with underlying kidney disease (e.g., diabetic nephropathy, RAS) because they lower glomerular hydrostatic pressure by dilating the efferent arteriole. However, they are contraindicated in bilateral renal artery stenosis and must be avoided in pregnancy due to fetal renal damage risk.
- Hereditary Angioedema: Patients with C1 esterase inhibitor deficiency (HAE) should never take ACE inhibitors or ARBs because these drugs cause dangerous buildup of bradykinin, triggering angioedema.
- Prolactinoma Management: The first-line treatment for hyperprolactinemia is a dopamine agonist (e.g., Bromocriptine). This works by inhibiting prolactin release from the pituitary gland and also helps treat hypogonadotropic hypogonadism caused by high prolactin.
- Parkinsonism: Drug-induced parkinsonism (from antipsychotics) can be treated with anticholinergic agents (Benztropine, Trihexyphenidyl) or dopamine agonists (Bromocriptine).
Learning objectives
- Identify the mechanism of acetaminophen hepatotoxicity and appropriate antidotal therapy (NAC).
- Predict the risk of acute kidney injury when initiating ACE inhibitors in patients with bilateral renal artery stenosis.
- Differentiate the indications for using ACE inhibitors/ARBs, recognizing their role as renal protective agents in specific comorbidities (e.g., diabetes, CKD).
- Recognize the contraindications to ACE inhibitors and ARBs, specifically in pregnancy and hereditary angioedema.
- Understand the endocrine feedback loop disrupted by hyperprolactinemia and the pharmacological rationale for dopamine agonist use.
Board exam buzzwords